Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
Morales
J M
JM
Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. jmorales@h120.es
Andrés
A
A
Morales
E
E
Herrero
J C
JC
Cubas
A
A
Praga
M
M
Hernández
E
E
Ortuño
T
T
Dominguez-Gil
B
B
Carreño
A
A
Delgado
M
M
Manzanares
C
C
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D004359:Drug Therapy, Combination; D005060:Europe; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology; D013030:Spain; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus